NCT00567567 2022-04-28
Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
Children's Oncology Group
Phase 3 Completed
Children's Oncology Group
Samsung Medical Center
Children's Oncology Group
Children's Oncology Group
Memorial Sloan Kettering Cancer Center